MACQUARIE GROUP LTD - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$79,340,000
-17.3%
1,579,842
+4.1%
0.10%
-9.1%
Q2 2023$95,943,000
+42.4%
1,518,086
+1.4%
0.11%
+37.5%
Q1 2023$67,367,000
+17.3%
1,497,386
+14.2%
0.08%
+17.6%
Q4 2022$57,424,000
-32.3%
1,310,750
+1.9%
0.07%
-34.6%
Q3 2022$84,815,000
+31.7%
1,286,589
+0.9%
0.10%
+44.4%
Q2 2022$64,394,000
-18.2%
1,274,889
+3.4%
0.07%
+20.0%
Q1 2022$78,760,000
-42.4%
1,232,928
-3.4%
0.06%
-47.4%
Q4 2021$136,754,000
+2.7%
1,276,762
-1.4%
0.11%0.0%
Q3 2021$133,182,000
+30.5%
1,295,418
+11.6%
0.11%
+35.7%
Q2 2021$102,074,000
+24.7%
1,160,451
+37.9%
0.08%
-27.6%
Q1 2021$81,830,000
-12.5%
841,618
+0.9%
0.12%
-15.3%
Q4 2020$93,556,000
+32.7%
834,203
+9.7%
0.14%
+15.1%
Q3 2020$70,504,000
+357.6%
760,565
+285.0%
0.12%
+340.7%
Q2 2020$15,408,000
+835.5%
197,538
+601.4%
0.03%
+800.0%
Q1 2020$1,647,000
+64.5%
28,164
+125.3%
0.00%
+200.0%
Q4 2019$1,001,000
-88.4%
12,498
-89.4%
0.00%
-92.9%
Q3 2019$8,637,000117,5580.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders